Aim: The aim of this work was to carry out a screen for methicillin-resistant Staphylococcus aureus (S. aureus) in nasal cavity of patients in the intensive care units of the University Hospital Center (UHC) and the Central Hospital of Yaounde (CHY) in Cameroon. Study Design: A cross-sectional descriptive study was carried out. Pace and Duration of the Study: Collection of nasal swab was done in Intensive Care Unit of University Teaching Hospital of Yaounde, and Intensive Care Unit of Central Hospital of Yaounde. Identification and susceptibility test were done in bacteriology laboratory of University Hospital Center, Yaounde between August 2018 and March 2019. Methods: Nasal swabs were collected from patients by performing rotation in each nose. The identification of bacteria was carried out by observation of mannitol fermentation on Chapman agar, catalase, coagulase and DNAse tests. The susceptibility test was carried out by the method of diffusion of the discs in Mueller-Hinton agar. Results: A total of 29 S. aureus were identified from 127 patients of which 44.10% were women  and 55.90% were men. The antibiotic resistance profile showed cross-resistance of S. aureus between cefoxitin and others antibiotics with high resistance of amoxicillin, Amoxi / Clavulanic, fusidic acid, gentamycin and tetracycline with rates ranging from 62% to 82%. We detected 58.62% resistant species to cefoxitin and 51.72% were resistant to vancomycin. Statistical analysis found that there was not association between age groups, gender with nasal carriage of S. aureus. However there was an association (P=0,0060) between the hospital attended and the portage of S. aureus. Conclusion: The prevalence of Methicillin-resistant S. aureus (MRSA) is quite high in intensive care patients. Staphylococcus aureus isolated from carriers also shows resistance to others antibiotics. This can increase the incidence of nosocomial infections. There is a need to implement effective control strategies to prevent infection cross transmission in intensive care Units.

No abstract

Aims: The aim of this study is to evaluate in vitro the antifungal activity of virgin coconut oil and the white palm kernel oil on the growth of six species of the genus Candida. Study Design: This study is an experimental study. Place and Duration of the Study: Department of Microbiology, Laboratory of Microbiology of the University of Yaoundé I. Laboratory of Bacteriology, Yaoundé University teaching Hospital between April to September 2017. Methodology: We included six species of Candida. The method of diffusion discs in agar medium was used for Sensitivity tests and macro-dilution in liquid medium was used for dilution. Results: Majority of the species tested were resistant to conventional antifungals used. Candida hoemulonii was the most sensitive species to virgin coconut oil with percentages of inhibitions higher than 50 % when the concentration of oil was only 3.125 mg/mL and a maximum inhibition percentage of 90.10 % when the concentration of oil was 100 mg/mL. Candida albicans, was the least susceptible species to virgin coconut oil with a maximum inhibition percentage of 59.85 % when the concentration of oil was 100 mg/mL.  Candida lipolytica was the most sensitive specie to white palm kernel oil with a maximum inhibition percentage of 90,26 % when the concentration of oil was 100 mg/mL and Candida parapsilosis was the least susceptible species to white palm kernel oil with a maximum inhibition percentage of 52,69 % at the same concentration. In addition, the white palm kernel oil which was more active (P˂0.05) than virgin coconut oil was introduced in the Sabouraud broth and the MIC and MFC obtained with Fluconazole was lower on Candida albicans and Candida parapsilosis compared to activity of Fluconazole without palm kernel oil in the medium. Nystatin showed also lower MIC and MFC values on Candida parapsilosis when palm kernel oil was present in the culture medium. Conclusion: These results prove that these oils can be used to develop antifungals drugs.